Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis

Does damage cause inflammation? Revisiting the link between joint damage and inflammation

(2009) J S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

(2009) G R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

New advances in the management of juvenile idiopathic arthritis--2: The era of biologicals

(2009) M W Beresford et al.   Archives of Disease in Childhood-Education and Practice Edition

Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab

(2009) María M. Katsicas et al.   CLINICAL RHEUMATOLOGY

Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic Arthritis: a Cohort Study of 761 Consecutive Cases

(2009) A. LURATI et al.   JOURNAL OF RHEUMATOLOGY

Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents

(2009) R. A.G. RUSSO et al.   JOURNAL OF RHEUMATOLOGY

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

(2009) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study

(2008) M Hoff et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Serious infections during anti-TNFα treatment in rheumatoid arthritis patients

(2008) Ennio Giulio Favalli et al.   AUTOIMMUNITY REVIEWS

Update on biologics in juvenile idiopathic arthritis

(2008) Norman T Ilowite   CURRENT OPINION IN RHEUMATOLOGY

The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment

(2008) Florence Kanakoudi-Tsakalidou et al.   CYTOKINE

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE